EMILIO
ESTEBAN GONZALEZ
Profesor Titular de Universidad
Hannover Medical School
Hanóver, AlemaniaPublicaciones en colaboración con investigadores/as de Hannover Medical School (1)
2014
-
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 3, pp. 286-296